Having trouble accessing articles? Reset your cache.

Algodign: From Russia with data

When he co-founded Protein Design Labs Inc., Cary Queen brought to the company the idea of using computer modeling to improve proteins - antibodies in the case of PDLI. Now, as chairman of Algodign Inc., he's expanding the idea to small molecules. Although not the first company to use computer-based drug design, Algodign believes its software offers advantages compared to competing

Read the full 614 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE